Clinical trial
Sertraline vs. Venlafaxine XR
NCT00179283 · Vanderbilt University, Other · Completed
Key facts
| NCT number | NCT00179283 |
|---|---|
| Title | Sertraline vs. Venlafaxine XR |
| Official title | A Multi-center, Randomized, Double-blind, Parallel-group Study of Sertraline vs. Venlafaxine XR in the Acute Treatment of Outpatients With Major Depressive Disorder |
| Lead sponsor | Vanderbilt University, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Drug |
| Interventions | sertraline, venlafaxine XR |
| Enrollment | 20 |
| Start date | Apr 1, 2002 |
| Completion | Apr 1, 2003 |
| First posted | Sep 15, 2005 |
| Last update posted | Jun 2, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: